Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | Thiophene | HCID 8030 | — |
| Edukt | Potassium Acetate | HCID 517044 | — |
| Edukt | Norastemizole hydrobromide | HCID 3018631 | — |
| Edukt | 1-Benzyl-3-piperidone hydrochloride hydrate | HCID 3084924 | — |
| Edukt | HCID 178418361 | HCID 178418361 | — |
| Katalysator | Palladium | HCID 23938 | — |
| Lösungsmittel | Ethanol | HCID 702 | — |
| Lösungsmittel | 2-Methoxyethanol | HCID 8019 | — |
| Produkt | 2-Aminobenzimidazole | HCID 13624 | — |
Reaktionsschritte
A mixture of 25 parts of 1(phenylmethyl)-3-piperidinone hydrochloride, 55 parts of 1-[(4-fluorophenyl)methyl]-N-(4-piperidinyl)-1H-benzimidazol-2-amine dihydrobromide, 1 part of a solution of thiophene in ethanol 4%, 50 parts of potassium acetate and 500 parts of 2-methoxyethanol was hydrogenated at normal pressure and at 50° C. with 5 parts of palladium-on-charcoal catalyst 10%. After the calculated amount of hydrogen was taken up, the catalyst was filtered off and the filrate was evaporated. The residue was taken up in water and the whole was alkalized with sodium hydroxide. The product was extracted with dichloromethane. The extract was dried, filtered and evaporated. The residue was crystallized twice from acetonitrile. The product was filtered off and dried, yielding 9.75 parts of 1-[(4-fluorophenyl)methyl]-N-[1'-(phenylmethyl)-[1,3'-fluorophenyl)methyl]-N-[1'-(phenylmethyl)-[1,3'-bipiperidin]-4yl[-1H-benzimidazol-2-amine; mp. 174.6° C. (intermediate 70).
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | USRE033833 |
|---|
| Quelldatensatz | uspto-grants-1992_02 |
|---|
| ORD ID | ord-555280e794774d178d0da1b678dc167c |
|---|
| Quellennotiz | uspto-grants-1992_02 |
|---|